Navigation Links
Maroon 5 Lead Singer Adam Levine Raises Awareness of Attention-Deficit/Hyperactivity Disorder in Young Adults and Adults With "Own It"
Date:6/20/2011

ents, according to the Centers for Disease Control and Prevention (CDC).  The disorder is also estimated to affect 4.4 percent of US adults aged 18 to 44 based on results from the National Comorbidity Survey Replication.  When this percentage is extrapolated to the full US population aged 18 and over, approximately 10 million adults are believed to have ADHD.

The specific etiology of ADHD is unknown, and there is no single diagnostic test for this disorder. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources, utilizing diagnostic criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR®) or International Classification of Diseases, 10th revision (ICD-10).

Although there is no cure for ADHD, there are accepted treatments that have been demonstrated to improve symptoms.  Standard treatments include educational approaches, psychological therapies, which may include behavioral modification, and/or medication.  For further information please contact:MediaMatthew Cabreymcabrey@shire.com

+1 484 595 8248Cori Blair (Porter Novelli for Shire)cori.blair@porternovelli.com

+1 212 601 8248Evelyn Green (ADDA)info@add.org

+1 800 939 1019Susan Buningh (CHADD) Susan_Buningh@chadd.org

+1 301 306 7070 x102SHIRE PLCShire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the exten
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
2. World-Renowned Singer Youssou NDour Launches NightWatch Program
3. Segal McCambridge Singer & Mahoney, Ltd. and Greenberg Traurig, LLP Obtain Three Defense Verdicts for I-Flow in Oregon Infusion Pump Cases
4. Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors
5. Globus Medical Raises $110 Million in Series E Financing Round
6. EntreMed Raises $20 Million to Support Clinical Development Program
7. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
8. Romark Laboratories Raises $18 Million in Institutional Financing
9. Light Sciences Oncology Raises $40.1 Million in Series C Financing
10. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
11. ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , September 23, 2014 ... has announced the addition of the  "Large ... to their offering.  ,     ... drug delivery market holds significant potential for ... vials and painful needles to the modern-day ...
(Date:9/23/2014)... SAN FRANCISCO , Sept. 23, 2014  SiteOne ... round of equity financing. Led by Sears Capital Management ... and Joe Zakrzewski , the $1.5 million financing ... inhibitor program for pain and to further develop its ... other pain indications. In conjunction with the ...
(Date:9/23/2014)... September 23, 2014 According ... by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), ... Orthopedics) - Global Forecasts to 2019", published by ... forecast period of 2014 to 2019. The market ... at CAGR of 9.6% from 2014 to 2019. ...
Breaking Medicine Technology:Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 4
... Oct. 12, 2011 Reportlinker.com announces that ... in its catalogue: ... Region 2010-2014 ... the Peripheral Vascular Devices market in the ...
... (NYSE: BSX ) will webcast its conference call ... 2011 on Thursday, October 20, at 8:00 a.m. ET. ... becomes Boston Scientific,s Chief Executive Officer on October 17, and ... A live webcast of the conference call will be ...
Cached Medicine Technology:Peripheral Vascular Device Market in the APAC Region 2010-2014 2Boston Scientific To Webcast Conference Call Discussing Third Quarter 2011 Financial Results 2
(Date:9/23/2014)... (PRWEB) September 23, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... 5, that its Private Label Jalapeno Bagels are recalled ... stones. Publix Jalapeno Bagels were sold in ... department. , Taking into consideration the latest developments, ...
(Date:9/23/2014)... 23, 2014 (HealthDay News) -- A test used to diagnose ... where certain lung infections are more common, a new analysis ... is through the use of what,s known as functional imaging. ... FDG-PET is used, according to the study authors. Cancerous ... parts of the lungs that don,t have cancer, according ...
(Date:9/23/2014)... Grinnell Mutual seeks submissions from the public ... Working Together Making It Better will provide grants ... positively impacting their communities. , “So many people ... a better places,” said Grinnell Mutual ... “Their leadership—as coaches, as volunteers, as mentors—help to ...
(Date:9/23/2014)... who are already obese as teenagers could grow up ... peers of normal weight. So says Petter Lundborg of ... Rooth of Linneas University and Lund University, all in ... United Kingdom and the United States, and the results ... , The researchers analyzed large-scale data of 145,193 Swedish-born ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 ... allergic rhinitis (AR) is highly fragmented, with ... SIT formulations available, under different regulatory restrictions, ... markets. Europe has the most developed market, ... and allergen immunotherapy tablets (AITs) all being ...
Breaking Medicine News(10 mins):Health News:Publix Private Label Jalapeno Bagels Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Note to young men: Fat doesn't pay 2Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 2Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 3Health News:Allergen extract Allergic Rhinitis Specific Immunotherapy Market to Grow $688.3m by 2018 Says a New Report Available at MarketOptimizer.org 4
... and community for decades, PHILADELPHIA, Nov. 11 ... leading health insurer, turns 70,years old. While health ... 1938, experts agree that access to affordable,quality health ... was a key,consideration when millions cast their vote ...
... Introducing ReBound(TM) the Revolution in Thermotherapy, ALAMEDA, ... and,ReGear Life Sciences announced today the introduction of ... to treat pain, muscle,spasms, and joint contractures using ... for providing state-of-the-art injury treatment systems,to the physical ...
... triglycerides throughout the body , , TUESDAY, Nov. 11 (HealthDay ... the risk of high blood pressure in women who ... of a new study by U.S. researchers who analyzed ... Study. , Lipoprotein particles carry cholesterol and triglycerides throughout ...
... walls as thick as that of a middle-aged person ... days are 13 going on 45, at least when ... presented Tuesday at the American Heart Association,s annual scientific ... representative of someone three decades older. , "These data ...
... NEW YORK, Nov. 11 Today, the ... the results of a,nationwide survey on the ... "Unfortunately, APIC failed to connect the dots,",says ... to Reduce Infection,Deaths (RID). "The new data ...
... 11 Pam Kreager, Director of,Clinical Quality ... Term,Care Group, Inc. (LTCG), has been elected ... (LTCIF). The Long Term Care International Forum,( ... is to promote,efficiency, effectiveness and high standards ...
Cached Medicine News:Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 2Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 3Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 4Health News:Independence Blue Cross Celebrates 70 Years Of Service In Southeastern Pennsylvania 5Health News:Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market 2Health News:Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market 3Health News:Lipoprotein Levels May Predict Women's Hypertension Risk 2Health News:Obese Kids Have Old Arteries 2Health News:Obese Kids Have Old Arteries 3Health News:APIC Covers Up Extent and Causes of Deadly C. diff 2Health News:Long Term Care International Forum names LTCG's Pam Kreager as President 2
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
... of both worlds, the PeaceKeeper 20 ... latest addition to the Wet-Field comprehensive ... instruments for ophthalmic surgery. Combining highly ... and backflush functionality in a single ...
...
...
Medicine Products: